 <h1>Sorafenib Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of sorafenib include:</b> alopecia, arthralgia, desquamation, diarrhea, exfoliation of skin, fatigue, headache, hemorrhage, hypertension, hypophosphatemia, increased serum lipase, lymphocytopenia, neutropenia, palmar-plantar erythrodysesthesia, peripheral sensory neuropathy, pruritus, skin rash, weight loss, increased amylase, and xeroderma.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to sorafenib: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, sorafenib may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking sorafenib:</p><p>
<i>More common</i>
</p><ul>
<li>Bleeding gums</li>
<li>blistering, peeling, redness, or swelling of the palms of the hands or bottoms of the feet</li>
<li>bloating of the abdomen or stomach</li>
<li>blood in the urine or stools</li>
<li>blurred vision</li>
<li>clay-colored stools</li>
<li>coughing up blood</li>
<li>dark urine</li>
<li>difficulty with breathing or swallowing</li>
<li>dizziness</li>
<li>headache</li>
<li>increased menstrual flow or vaginal bleeding</li>
<li>light-colored stools</li>
<li>nausea</li>
<li>nervousness</li>
<li>nosebleeds</li>
<li>paralysis</li>
<li>pounding in the ears</li>
<li>prolonged bleeding from cuts</li>
<li>red or black, tarry stools</li>
<li>red or dark brown urine</li>
<li>slow or fast heartbeat</li>
<li>stomach pain</li>
<li>tightness in the chest</li>
<li>vomiting</li>
<li>vomiting of blood</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bone pain</li>
<li>burning feeling in the chest or stomach</li>
<li>chest pain or discomfort</li>
<li>chills</li>
<li>clammy skin</li>
<li>confusion</li>
<li>constipation</li>
<li>cough</li>
<li>decreased urine production</li>
<li>depressed mood</li>
<li>difficulty with moving</li>
<li>dry skin and hair</li>
<li>enlarged pupils (black part of the eye)</li>
<li>fainting</li>
<li>feeling cold</li>
<li>fever</li>
<li>hair loss</li>
<li>hearing loss</li>
<li>hives, itching, skin rash</li>
<li>hoarseness or husky voice</li>
<li>increase in heart rate</li>
<li>increased sensitivity of the eyes to light</li>
<li>increased sweating, possibly with fever or cold</li>
<li>increased thirst</li>
<li>indigestion</li>
<li>joint pain or swelling</li>
<li>lightheadedness</li>
<li>loss of appetite</li>
<li>loss of the ability to use or understand speech or language</li>
<li>lower back or side pain</li>
<li>muscle cramps, pain, or stiffness</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>painful or difficult urination</li>
<li>pains in the stomach, side, or abdomen, possibly radiating to the back</li>
<li>pale skin</li>
<li>pinpoint red spots on the skin</li>
<li>rapid breathing</li>
<li>reddening of the skin, especially around the ears</li>
<li>ringing, buzzing, or other unexplained noise in the ears that continues</li>
<li>seizures</li>
<li>severe chest pain</li>
<li>severe headache</li>
<li>shivering</li>
<li>skin rash that is encrusted, scaly, and oozing</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>stiff or sore neck</li>
<li>stomach discomfort or upset</li>
<li>sweating</li>
<li>swelling of the ankles or hands</li>
<li>swelling of the eyes, face, or inside of the nose</li>
<li>swollen glands</li>
<li>trouble breathing with exertion</li>
<li>unpleasant breath odor</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>weight gain</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blistering, peeling, or loosening of the skin</li>
<li>diarrhea</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of sorafenib may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Burning, tingling, numbness or pain in the hands, arms, feet, or legs</li>
<li>numbness, pain, tingling, or unusual sensations in palms of the hands or bottom of the feet</li>
<li>sensation of pins and needles</li>
<li>stabbing pain</li>
<li>thinning of the hair</li>
<li>weight loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Acne</li>
<li>belching</li>
<li>burning, itching, and pain in hairy areas</li>
<li>cracked lips</li>
<li>cracks in the skin</li>
<li>decreased appetite</li>
<li>decreased interest in sexual intercourse</li>
<li>discouragement</li>
<li>dry mouth</li>
<li>feeling of warmth</li>
<li>feeling sad or empty</li>
<li>flushing or red skin</li>
<li>gas</li>
<li>general feeling of discomfort or illness</li>
<li>heartburn</li>
<li>inability to have or keep an erection</li>
<li>irritability</li>
<li>lack or loss of strength</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>loss of heat from the body</li>
<li>loss of interest or pleasure</li>
<li>mouth pain</li>
<li>pus at the root of the hair</li>
<li>red face, neck, arms, and occasionally, upper chest</li>
<li>red, swollen skin</li>
<li>runny nose</li>
<li>scaly skin</li>
<li>sunken eyes</li>
<li>swelling of the breasts or breast soreness in both men and women</li>
<li>swelling or inflammation of the mouth</li>
<li>tenderness in the stomach area</li>
<li>thirst</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
<li>unusually warm skin</li>
<li>wrinkled skin</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to sorafenib: oral tablet</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (39%), nausea, vomiting, constipation, abdominal pain, mouth pain</p>
<p><b>Common</b> (1% to 10%): Stomatitis, dry mouth, glossodynia, dyspepsia, dysphagia, gastroesophageal reflux disease, mucosal inflammation</p>
<p><b>Uncommon</b> (0.1% to 1%): Pancreatitis, gastritis, GI perforations<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Pruritus (20%), dry skin (13%), erythema (10%), rash, alopecia, hand foot skin reaction</p>
<p><b>Common</b> (1% to 10%): Keratoacanthoma/squamous cell cancer of the skin, dermatitis exfoliative, acne, skin desquamation, hyperkeratosis</p>
<p><b>Uncommon</b> (0.1% to 1%): Eczema, erythema multiforme</p>
<p><b>Rare</b> (less than 0.1%): Radiation recall dermatitis, Stevens-Johnson syndrome (SJS), leucocytoclastic vasculitis, toxic epidermal necrolysis (TEN)<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Hypothyroidism</p>
<p><b>Uncommon</b> (0.1% to 1%): Hyperthyroidism<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (41%)</p>
<p><b>Common</b> (1% to 10%): Congestive heart failure, myocardial ischemia, myocardial infarction</p>
<p><b>Rare</b> (less than 0.1%): QT prolongation<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Lymphopenia, GI hemorrhage, respiratory tract hemorrhage, cerebral hemorrhage, hypertension</p>
<p><b>Common</b> (1% to 10%): Leukopenia, neutropenia, anemia, thrombocytopenia, flushing</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypertensive crisis, INR abnormal, prothrombin level abnormal<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough (15%), dysphonia (13%), dyspnea (12%)</p>
<p><b>Common</b> (1% to 10%): Rhinorrhea, dysphonia, hoarseness, epistaxis</p>
<p><b>Uncommon</b> (0.1% to 1%): Interstitial lung disease-like events (e.g., pneumonitis, radiation pneumonitis, acute respiratory distress)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache</p>
<p><b>Common</b> (1% to 10%): Peripheral sensory neuropathy, dysgeusia, paresthesia, dizziness</p>
<p><b>Uncommon</b> (0.1% to 1%): Reversible posterior leukoencephalopathy (sometimes fatal)</p>
<p><b>Frequency not reported</b>: Encephalopathy (sometimes fatal)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Pain in extremity (15%), joint pain (10%), arthralgia, bone pain</p>
<p><b>Common</b> (1% to 10%): Myalgia, muscle spasm</p>
<p><b>Rare</b> (less than 0.1%): Rhabdomyolysis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Folliculitis, influenza-like illness<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity reactions (e.g., skin reactions, urticaria), anaphylactic reaction</p>
<p><b>Rare</b> (less than 0.1%): Angioedema<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (11%), hypophosphatemia, weight loss, increased amylase, increased lipase</p>
<p><b>Common</b> (1% to 10%): Hypocalcemia, hypokalemia, hyponatremia</p>
<p><b>Uncommon</b> (0.1% to 1%): Dehydration, transient increase in blood alkaline phosphatase<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Erectile dysfunction, urinary tract infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Gynecomastia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Transient increase in transaminases</p>
<p><b>Uncommon</b> (0.1% to 1%): Bilirubin increased, jaundice, cholecystitis, cholangitis</p>
<p><b>Rare</b> (less than 0.1%): Drug induced hepatitis (sometimes fatal), nephrotic syndrome<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (17%), pain </p>
<p>fever</p>
<p><b>Common</b> (1% to 10%): Tinnitus, asthenia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Nexavar (sorafenib)." Bayer Pharmaceutical Inc, West Haven, CT. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Lenvatinib vs sorafenib: for first line treatment in HCC?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about sorafenib</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>14 Reviews</li>
<li>Drug class: multikinase inhibitors</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Sorafenib &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Nexavar</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Thyroid Cancer</li>
<li>Hepatic Tumor</li>
<li>Hepatocellular Carcinoma</li>
<li>Renal Cell Carcinoma</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to sorafenib: oral tablet</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (39%), nausea, vomiting, constipation, abdominal pain, mouth pain</p><p><b>Common</b> (1% to 10%): Stomatitis, dry mouth, glossodynia, dyspepsia, dysphagia, gastroesophageal reflux disease, mucosal inflammation</p><p><b>Uncommon</b> (0.1% to 1%): Pancreatitis, gastritis, GI perforations<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Pruritus (20%), dry skin (13%), erythema (10%), rash, alopecia, hand foot skin reaction</p><p><b>Common</b> (1% to 10%): Keratoacanthoma/squamous cell cancer of the skin, dermatitis exfoliative, acne, skin desquamation, hyperkeratosis</p><p><b>Uncommon</b> (0.1% to 1%): Eczema, erythema multiforme</p><p><b>Rare</b> (less than 0.1%): Radiation recall dermatitis, Stevens-Johnson syndrome (SJS), leucocytoclastic vasculitis, toxic epidermal necrolysis (TEN)<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Hypothyroidism</p><p><b>Uncommon</b> (0.1% to 1%): Hyperthyroidism<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (41%)</p><p><b>Common</b> (1% to 10%): Congestive heart failure, myocardial ischemia, myocardial infarction</p><p><b>Rare</b> (less than 0.1%): QT prolongation<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Lymphopenia, GI hemorrhage, respiratory tract hemorrhage, cerebral hemorrhage, hypertension</p><p><b>Common</b> (1% to 10%): Leukopenia, neutropenia, anemia, thrombocytopenia, flushing</p><p><b>Uncommon</b> (0.1% to 1%): Hypertensive crisis, INR abnormal, prothrombin level abnormal<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough (15%), dysphonia (13%), dyspnea (12%)</p><p><b>Common</b> (1% to 10%): Rhinorrhea, dysphonia, hoarseness, epistaxis</p><p><b>Uncommon</b> (0.1% to 1%): Interstitial lung disease-like events (e.g., pneumonitis, radiation pneumonitis, acute respiratory distress)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache</p><p><b>Common</b> (1% to 10%): Peripheral sensory neuropathy, dysgeusia, paresthesia, dizziness</p><p><b>Uncommon</b> (0.1% to 1%): Reversible posterior leukoencephalopathy (sometimes fatal)</p><p><b>Frequency not reported</b>: Encephalopathy (sometimes fatal)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Pain in extremity (15%), joint pain (10%), arthralgia, bone pain</p><p><b>Common</b> (1% to 10%): Myalgia, muscle spasm</p><p><b>Rare</b> (less than 0.1%): Rhabdomyolysis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Folliculitis, influenza-like illness<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity reactions (e.g., skin reactions, urticaria), anaphylactic reaction</p><p><b>Rare</b> (less than 0.1%): Angioedema<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (11%), hypophosphatemia, weight loss, increased amylase, increased lipase</p><p><b>Common</b> (1% to 10%): Hypocalcemia, hypokalemia, hyponatremia</p><p><b>Uncommon</b> (0.1% to 1%): Dehydration, transient increase in blood alkaline phosphatase<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Erectile dysfunction, urinary tract infection</p><p><b>Uncommon</b> (0.1% to 1%): Gynecomastia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Transient increase in transaminases</p><p><b>Uncommon</b> (0.1% to 1%): Bilirubin increased, jaundice, cholecystitis, cholangitis</p><p><b>Rare</b> (less than 0.1%): Drug induced hepatitis (sometimes fatal), nephrotic syndrome<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (17%), pain </p><p>fever</p><p><b>Common</b> (1% to 10%): Tinnitus, asthenia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Nexavar (sorafenib)." Bayer Pharmaceutical Inc, West Haven, CT. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Lenvatinib vs sorafenib: for first line treatment in HCC?</li>
</ul><h2>More about sorafenib</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>14 Reviews</li>
<li>Drug class: multikinase inhibitors</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Sorafenib &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Thyroid Cancer</li>
<li>Hepatic Tumor</li>
<li>Hepatocellular Carcinoma</li>
<li>Renal Cell Carcinoma</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>